HXBM Stock Chart & Stats
$3.70
$0.00(0.00%)
At close: 4:00 PM EST
$3.70
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$1.00 - $6.45
Previous CloseN/A
Volume13.00
Average Volume (3M)58.00
Market Cap
$402.23K
Enterprise Value-$817.09K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.19
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding224,708
10 Day Avg. Volume100
30 Day Avg. Volume58
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.29
Price to Sales (P/S)0.56
P/FCF Ratio-0.75
Enterprise Value/Market Cap-2.03
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
HXBM FAQ
What was Helix BioMedix Inc’s price range in the past 12 months?
Helix BioMedix Inc lowest stock price was $1.00 and its highest was $6.45 in the past 12 months.
What is Helix BioMedix Inc’s market cap?
Helix BioMedix Inc’s market cap is $402.23K.
When is Helix BioMedix Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Helix BioMedix Inc’s earnings last quarter?
Currently, no data Available
Is Helix BioMedix Inc overvalued?
According to Wall Street analysts Helix BioMedix Inc’s price is currently Overvalued.
Does Helix BioMedix Inc pay dividends?
Helix BioMedix Inc does not currently pay dividends.
What is Helix BioMedix Inc’s EPS estimate?
Helix BioMedix Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Helix BioMedix Inc have?
Helix BioMedix Inc has 224,708 shares outstanding.
What happened to Helix BioMedix Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Helix BioMedix Inc?
Currently, no hedge funds are holding shares in HXBM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Helix BioMedix Inc
Helix BioMedix, Inc. is a biopharmaceutical company, which focuses on drug development for treatment of rare dermatological diseases, such as Xeroderma Pigmentosum. The company was founded in 1988 and is headquartered in Bothell, WA.
Technical Analysis
Scinai Immunotherapeutics
―
Aditxt
―
Dermata Therapeutics
―
CERo Therapeutics Holdings
―
CDT Equity
―